论文部分内容阅读
目的评价蛛网膜下腔出血后脑血管痉挛患者采取尼莫地平治疗的临床疗效。方法将98例蛛网膜下腔出血后脑血管痉挛患者纳入本次研究,按随机数字表法分为两组,对照组49例给予常规方法治疗,观察组49例在常规方法治疗的基础上重点给予尼莫地平治疗,对比两组患者的临床治疗效果。结果观察组治疗总有效率为95.92%,高于对照组的65.31%,两组比较差异有统计学意义(P<0.05)。观察组并发症发生率为6.12%,低于对照组的20.41%,两组比较差异有统计学意义(P<0.05)。此外,观察组病死率为2.04%,低于对照组的8.16%,两组比较差异有统计学意义(P<0.05)。结论对于蛛网膜下腔出血后脑血管痉挛患者,采取尼莫地平治疗疗效显著,可降低并发症发生率及病死率,进而提高患者的生存质量,值得在临床中推广及应用。
Objective To evaluate the clinical efficacy of nimodipine in patients with cerebral vasospasm after subarachnoid hemorrhage. Methods A total of 98 patients with cerebral vasospasm after subarachnoid hemorrhage were enrolled in this study. According to the random number table, they were divided into two groups. 49 patients in the control group were treated by conventional method. 49 patients in the observation group were given priority on the basis of routine treatment Nimodipine treatment, the clinical efficacy of two groups of patients compared. Results The total effective rate of the observation group was 95.92%, which was higher than that of the control group (65.31%). There was significant difference between the two groups (P <0.05). The incidence of complications in the observation group was 6.12%, which was lower than that in the control group (20.41%). The difference between the two groups was statistically significant (P <0.05). In addition, the case fatality rate was 2.04% in the observation group, which was lower than 8.16% in the control group. There was significant difference between the two groups (P <0.05). Conclusion For patients with cerebral vasospasm after subarachnoid hemorrhage, the effect of nimodipine treatment is significant, which can reduce the incidence of complications and mortality, thereby improving the quality of life of patients, which is worth popularizing and applying in clinic.